GSK-3 is an RNA polymerase II phospho-CTD kinase
- PMID: 32374842
- PMCID: PMC7293024
- DOI: 10.1093/nar/gkaa322
GSK-3 is an RNA polymerase II phospho-CTD kinase
Abstract
We have previously found that UV-induced DNA damage causes hyperphosphorylation of the carboxy terminal domain (CTD) of RNA polymerase II (RNAPII), inhibition of transcriptional elongation and changes in alternative splicing (AS) due to kinetic coupling between transcription and splicing. In an unbiased search for protein kinases involved in the AS response to DNA damage, we have identified glycogen synthase kinase 3 (GSK-3) as an unforeseen participant. Unlike Cdk9 inhibition, GSK-3 inhibition only prevents CTD hyperphosphorylation triggered by UV but not basal phosphorylation. This effect is not due to differential degradation of the phospho-CTD isoforms and can be reproduced, at the AS level, by overexpression of a kinase-dead GSK-3 dominant negative mutant. GSK-3 inhibition abrogates both the reduction in RNAPII elongation and changes in AS elicited by UV. We show that GSK-3 phosphorylates the CTD in vitro, but preferentially when the substrate is previously phosphorylated, consistently with the requirement of a priming phosphorylation reported for GSK-3 efficacy. In line with a role for GSK-3 in the response to DNA damage, GSK-3 inhibition prevents UV-induced apoptosis. In summary, we uncover a novel role for a widely studied kinase in key steps of eukaryotic transcription and pre-mRNA processing.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures
References
-
- Kornblihtt A.R., Schor I.E., Alló M., Dujardin G., Petrillo E., Muñoz M.J.. Alternative splicing: A pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol. 2013; 14:153–165. - PubMed
-
- Dujardin G., Lafaille C., de la Mata M., Marasco L.E., Muñoz M.J., Le Jossic-Corcos C., Corcos L., Kornblihtt A.R.. How slow RNA polymerase II elongation favors alternative exon skipping. Mol. Cell. 2014; 54:683–690. - PubMed
-
- de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., Cramer P., Bentley D., Kornblihtt A.R.. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell. 2003; 12:525–532. - PubMed
-
- Schüller R., Forné I., Straub T., Schreieck A., Texier Y., Shah N., Decker T.M., Cramer P., Imhof A., Eick D.. Heptad-specific phosphorylation of RNA polymerase II CTD. Mol. Cell. 2016; 61:305–314. - PubMed
-
- Batsché E., Yaniv M., Muchardt C.. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 2006; 13:22–29. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
